Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPORT trial of preservative-free bimatoprost versus preservative-free latanoprost in ocular hypertension or glaucoma
2013-003490-10Phase 4Completed
- Sponsor
- AIBILI
- Start
- Aug 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of bimatoprost and latanoprost in ocular hypertension, Glaucoma and open-angle glaucoma (OAG) (2 arms), sponsored by AIBILI. Primary endpoint: Difference in mean intraocular pressure at 6 months. Started Aug 2013; status: completed.
02
Drugs
bimatoprostlatanoprost
03
Conditions
ocular hypertensionGlaucomaopen-angle glaucoma (OAG)
Beyond the preview
Go deeper on 2013-003490-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003490-10.